|Day Low/High||67.71 / 72.87|
|52 Wk Low/High||28.47 / 109.62|
2 stocks that promise returns similar to those garnered by PE powerhouses.
Mergers have biotechs and semiconductors up, but I'm looking elsewhere.
Desperado, why don't you come to your senses You been out ridin' fences for so long now. Oh, you're a hard one But I know that you got your reasons. These things that are pleasin' you Can hurt you somehow. -- The Eagles, Desperado I'm obviously not ...
Wall Street appeared to take pause ahead of tomorrow's jobs report.
Crude oil's two-day price rally continued to help lift markets.
UBNT reports today after close; here's how to play big swings tomorrow.
Days like Tuesday are almost an engraved invitation for the buyers to jump in.
A sharp selloff in crude kept stocks mostly in the red, though optimism ahead of Friday's jobs reports kept losses to a minimum on Thursday.
Oil prices erased their gains this week on less-than-expected stockpile reductions.
Crabtree Asset Management says that while shares of Facebook are up nine percent year-to-date, they still have room to climb higher.
The second half does not look promising for stocks as a whole in this increasingly expensive market, but investors still have a chance to earn sizable returns in individual stories.
Jim Cramer prefers Verizon to AT&T because it's levered to Apple's iPhone 7.
First Solar is a better choice than SolarCity for those interested in that sector, says Jim Cramer.
Jim Cramer says he doesn't think PepsiCo will disappoint on earnings, but if it does, investors should buy it.
First Solar and JA Solar offer opportunities in the alternative energy sector, even as SunEdison implodes.
Jim Cramer says watch shares of First Solar after this week’s analyst meeting.
TheStreet's Jim Cramer is on the floor of the NYSE talking MLB's Opening Day and answering social media questions.
Bullish technical pattern suggests crude could be headed over $40 a barrel.
Targets are $70 to the upside and $58 to the downside, based on options.
Lately, we've seen a complete repudiation of the concept of 'Don't Fight the Fed.'
Chart damage is spreading like a virus, but this stock seems immune.